Should the treatment of schizophrenia include old antipsychotic drugs? (Q34108518)

31 July 2017

1 reference

title

Should the treatment of schizophrenia include old antipsychotic drugs? (English)

1 reference

31 July 2017

0 references

2

Johnstone EC

1 reference

31 July 2017

Steel RM

1

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

Current Psychiatry Reports

31 July 2017

published in

1 reference

31 July 2017

volume

2

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

404-409

1 reference

Treatment of negative symptoms

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0023-5

Impact of clozapine on negative symptoms and on the deficit syndrome in refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0023-5

Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0023-5

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0023-5

Structural evaluation of the prefrontal cortex in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0023-5

Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0023-5

Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia

21 January 2018

1 reference

12 December 2020

The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics.

1 reference

12 December 2020

Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome.

1 reference

12 December 2020

The Risperidone Outcomes Study of Effectiveness (ROSE): a model for evaluating treatment strategies in typical psychiatric practice

1 reference

12 December 2020

Newer antipsychotics in treatment-resistant schizophrenia.

1 reference

12 December 2020

PET studies of dopamine receptors in relation to antipsychotic drug treatment

1 reference

12 December 2020

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

1 reference

12 December 2020

10.1007/S11920-000-0023-5

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1011888311

0 references

1 reference